JULIA KOCEMBA: Open Payments
NPI 1851865257 · ARLINGTON HEIGHTS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,686 in 131 payments from 19 companies in 2025. Trend: 2023 $2,593 · 2024 $2,038 · 2025 $2,686
Food & beverage: $2,506Education: $180
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 27 | $539 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $341 |
| ABBVIE INC. | 9 | $224 |
| Galderma Laboratories, L.P. | 18 | $219 |
| Incyte Corporation | 9 | $195 |
| Regeneron Healthcare Solutions, Inc. | 5 | $165 |
| Arcutis Biotherapeutics, Inc. | 15 | $138 |
| Lilly USA, LLC | 5 | $103 |
| Almirall LLC | 3 | $101 |
| Novartis Pharmaceuticals Corporation | 4 | $100 |
Products named: TREMFYA, DUPIXENT, OPZELURA, SKYRIZI, Zoryve, NEMLUVIO, TALTZ, SOFDRA.
Industry payments across IL — which companies pay providers there.
